Search
Timiperone
go.drugbank.com/drugs/DB20070ExperimentalTimiperone has a monoisotopic molecular weight of 397.16 Da. … The usage of the INN stem '-perone' in the name indicates that Timiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Mannomustine
go.drugbank.com/drugs/DB20616ExperimentalMannomustine has a monoisotopic molecular weight of 304.1 Da. … The usage of the INN stem '-mustine' in the name indicates that Mannomustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.
Duoperone
go.drugbank.com/drugs/DB20621ExperimentalDuoperone has a monoisotopic molecular weight of 514.17 Da. … The usage of the INN stem '-perone' in the name indicates that Duoperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Erocainide
go.drugbank.com/drugs/DB20634ExperimentalErocainide has a monoisotopic molecular weight of 376.23 Da. … The usage of the INN stem '-cain-' in the name indicates that Erocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.
Amiperone
go.drugbank.com/drugs/DB20685ExperimentalAmiperone has a monoisotopic molecular weight of 430.18 Da. … The usage of the INN stem '-perone' in the name indicates that Amiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.
Sofnobrutinib
go.drugbank.com/drugs/DB21626ExperimentalSofnobrutinib has a monoisotopic molecular weight of 498.19 Da. … The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.
Lacutoclax
go.drugbank.com/drugs/DB21657InvestigationalThe usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Lacutoclax has a monoisotopic molecular weight of 922.36 Da.
Vilzemetkib
go.drugbank.com/drugs/DB21704ExperimentalVilzemetkib has a monoisotopic molecular weight of 642.27 Da. … The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.
V590
go.drugbank.com/drugs/DB16437ExperimentalThe V590 vaccine was developed on Merck’s recombinant vesicular stomatitis virus (rVSV) platform that was previously used to develop its Ebola Zaire virus vaccine, ERVEBO®[A226818, L30573, L30578].
Tandutinib
go.drugbank.com/drugs/DB05465InvestigationalTyrosine kinases are enzymes involved in several cellular processes and are known to be activated in cancer cells to drive tumor growth. … The use of MLN518 to treat AML has been granted fast-track status by the U.S. Food and Drug Administration. Phase I/II trials are underway.